Tsuruha Holdings, Inc. · TSE:3391

Tsuruha — 2Q FY5/21 Earnings Presentation

27 slides from Tsuruha's earnings presentation, Dec 15, 2020

  1. Slide 1: Financial Results Presentation for 2Q FY5/21

    Listed on the First Section of the Tokyo Stock Exchange under securities code 3391 TSURUHA HOLDINGS INC. Financial Results Presentation for 2Q FY5/21 (May 16, 2020 to May 15, 2021) December 15, 2020 The Company’s plans, earnings forecasts, and strategies appearing in this presentation are based on t

  2. Slide 2: Agenda

    Presentation Materials for the First Half of FY5/21 Agenda TSURUHA HOLDINGS INC. I. Summary of Earnings Results for 2Q FY5/21 2 II. Initiatives and Policies for FY5/21 16 *The following abbreviations are used in this presentation: TGN: Tsuruha Group Drug & Pharmacy Nishinihon Inc. B&D: B&D Co.,Ltd.

  3. Slide 3: Summary of Earnings Results for 2Q FY5/21

    Presentation Materials for the First Half of FY5/21 TSURUHA HOLDINGS INC. Summary of Earnings Results for 2Q FY5/21

  4. Slide 4: Financial Highlights: Maintained growth in both revenue and profit

    Presentation Materials for the First Half of FY5/21 Financial Highlights TSURUHA HOLDINGS INC. Maintained growth in both revenue and profit 2Q of FY5/21 YTD Net sales Operating income billion ( % YoY) billion ( % YoY) *Includes 3 months of results for Drug Eleven (June 1 to August 31) Business React

  5. Slide 5: Consolidated Performance

    Presentation Materials for the First Half of FY5/21 Consolidated Performance TSURUHA HOLDINGS INC. 2Q of FY5/21 YTD *Includes 3 months of results for Drug Eleven (June 1 to August 31) (Million JPY / %) FY5/20 Plan FY5/21 Share Share Share YoY Vs. Plan Net sales Gross profit SG&A expenses Operating i

  6. Slide 6: Reference: Performance Excluding Drug Eleven

    Presentation Materials for the First Half of FY5/21 Reference: Performance Excluding Drug Eleven TSURUHA HOLDINGS INC. 2Q of FY5/21 YTD (Million JPY / %) FY5/20 Plan FY5/21 Share Share Share YoY Vs. Plan Net sales Gross profit SG&A expenses Operating income Ordinary income Net sales Gross profit SG&

  7. Slide 7: Quarterly Earnings Results

    Presentation Materials for the First Half of FY5/21 Quarterly Earnings Results TSURUHA HOLDINGS INC. FY5/21 Reference: Performance Excluding Drug Eleven 1Q 2Q 2Q Results Share YoY Results Share YoY Results Share YoY Net sales Net sales Gross profit Gross profit SG&A expenses SG&A expenses Operating

  8. Slide 8: Monthly Changes in Existing Store Sales

    Monthly Changes in Existing Store Sales Presentation Materials for the First Half of FY5/21 (Stores Open for 13 Months or More) TSURUHA HOLDINGS INC. *Excludes Drug Eleven FY5/21 FY5/20 Change due to reaction to Rising demand from the COVID- consumption tax hike in FY5/20 19 pandemic

  9. Slide 9: Details of Existing Store Sales

    Details of Existing Store Sales Presentation Materials for the First Half of FY5/21 (Stores Open for 13 Months or More) *Excludes Drug Eleven TSURUHA HOLDINGS INC. Number of Customers Unit Price of Products *Decline caused by charging for plastic shopping bags starting in July Sales Per Customer Num

  10. Slide 10: Store Openings and Closures

    Presentation Materials for the First Half of FY5/21 Store Openings and Closures TSURUHA HOLDINGS INC. Situation by Region Situation by Operating Company 2020 FY5/21 2020 FY5/21 End of End of FY5/20 Acquisitions, FY5/20 Acquisitions, Openings Closures Net change End of 2Q Openings Closures Net change

  11. Slide 11: Store Openings and Closures: Net Sales by Region and Company

    Presentation Materials for the First Half of FY5/21 Store Openings and Closures *Excludes Drug Eleven TSURUHA HOLDINGS INC. Net Sales by Region (%) Net Sales by Company (%) Share of total Existing store sales YoY Existing store sales YoY store sales 1H of FY5/21 FY5//19 FY5/20 1H of FY5/21 FY5//19 F

  12. Slide 12: Results by Product Group (Consolidated)

    Presentation Materials for the First Half of FY5/21 Results by Product Group (Consolidated) TSURUHA HOLDINGS INC. 2Q of FY5/21 YTD *Includes online sales (millions of JPY/%) Gross Net sales margin YoY Share YoY Pharmaceuticals Prescriptions OTC Products Cosmetics Misc. daily necessities Foods Other

  13. Slide 13: Reference: Results by Product Group (Excludes Drug Eleven)

    Presentation Materials for the First Half of FY5/21 Reference: Results by Product Group (Excludes Drug Eleven) TSURUHA HOLDINGS INC. Pharmaceuticals 2Q of FY5/21 YTD *Includes online sales (millions of JPY/%) • Rising gross margin of dispensing (→P13) • Downturn in seasonal products such as Gross co

  14. Slide 14: Dispensing Division Results

    Presentation Materials for the First Half of FY5/21 Dispensing Division Results TSURUHA HOLDINGS INC. Consolidated Results Reference: Results Excluding Drug Eleven 1H YTD 2Q of FY5/21 1H YTD 2Q Results YoY FY5/21 Results YoY Results YoY Results YoY Results YoY Dispensing Dispensing remuneration remu

  15. Slide 15: Private Brand Sales Results

    Presentation Materials for the First Half of FY5/21 Private Brand Sales Results *Excludes Drug Eleven TSURUHA HOLDINGS INC. Results by PB Category (millions of JPY/%) SKUs Share of sales SKUs Net sales *Product sales excluding Gross margin Kurashi Exclusive dispensing M’s one / products / Rhythm Tot

  16. Slide 16: SG&A Expenses

    Presentation Materials for the First Half of FY5/21 SG&A Expenses TSURUHA HOLDINGS INC. Consolidated Results *Includes Drug Eleven (millions of JPY/%) 1H FY5/19 1H FY5/20 2Q FY5/21 YoY YoY YoY Personnel Amount Personnel expenses expenses Share of • Exerting good control of sales expenses by rational

  17. Slide 17: Initiatives and Policies for FY5/21

    Presentation Materials for the First Half of FY5/21 TSURUHA HOLDINGS INC. Initiatives and Policies for FY5/21

  18. Slide 18: Targets for FY5/21 and Main Initiatives

    Presentation Materials for the First Half of FY5/21 Targets for FY5/21 and Main Initiatives TSURUHA HOLDINGS INC. Business Plan for FY5/21 Revised Plan Net sales Operating income billion ( % YoY) billion ( % YoY) *Includes 11.5 months of results for JR Kyushu Drug Eleven (June 1, 2020 to May 15, 202

  19. Slide 19: Plan for FY5/21 (1H and 2H)

    Presentation Materials for the First Half of FY5/21 Plan for FY5/21 (1H and 2H) TSURUHA HOLDINGS INC. (millions of JPY/%) Plan for 1H Results Plan for 2H Share YoY Share YoY FY5/21 Share YoY Net sales Gross profit SG&A expenses Operating income Ordinary income Net Income Attributable to Owners of th

  20. Slide 20: Store Opening Plan for FY5/21

    Presentation Materials for the First Half of FY5/21 Store Opening Plan for FY5/21 TSURUHA HOLDINGS INC. Store Opening Plan by Region (Consolidated) Store Opening Plan by Company (Consolidated) FY5/21 FY5/21 2020 2020 End of FY5/20 Acquisitions, End of FY5/20 Acquisitions, Openings Closures Net chang

  21. Slide 21: Acquisition of JR Kyushu Drug Eleven Co., Ltd.

    Presentation Materials for the First Half of FY5/21 Initiatives for FY5/21 TSURUHA HOLDINGS INC. Acquisition of JR Kyushu Drug Eleven Co., Ltd. Maximize integration synergies and improve profitability through scale merits Improve purchasing conditions Joint purchasing started in September Drug Eleve

  22. Slide 22: Expand PB centered on Kurashi Rhythm

    Presentation Materials for the First Half of FY5/21 Initiatives for FY5/21 TSURUHA HOLDINGS INC. Expand PB centered on Kurashi Rhythm Foster the Kurashi Rhythm brand by increasing SKU numbers and develop highly value-added products including exclusive products Roll out co-developed products with oth

  23. Slide 23: Promote app use and digital strategy

    Presentation Materials for the First Half of FY5/21 Initiatives for FY5/21 TSURUHA HOLDINGS INC. Promote app use and digital strategy Using digital tools for provision of customer service and counseling and establish a foundation to achieve 1to1 marketing Promote use of smart phone apps Promote new

  24. Slide 24: Other Initiatives

    Presentation Materials for the First Half of FY5/21 Other Initiatives TSURUHA HOLDINGS INC. Expand meat and Streamline working Oricon customer satisfaction rankings fresh produce hours management Tsuruha Improve management of Drug All-around No. 1 Remodeling of existing stores and introduction at wo

  25. Slide 25: Mid-Term Targets

    Presentation Materials for the First Half of FY5/21 Mid-Term Targets TSURUHA HOLDINGS INC. Net sales: Target for FY5/24 Stores: Number of stores Net sales (million yen)  Pursue specialization and convenience  Expand stores following the dominant area strategy  Expand lineup of PB products and enh

  26. Slide 26: The SDGs and Our Initiatives

    Presentation Materials for the First Half of FY5/21 The SDGs and Our Initiatives TSURUHA HOLDINGS INC. Our Business and the SDGs Individual Initiatives We make social Donation of proceeds from sale of plastic shopping bags Management contributions through Philosophy providing a health lifestyle Dona

  27. Slide 27: IR Inquiry

    IR Inquiry TSURUHA HOLDINGS INC. Investor Relations TEL: 011-783-2755 The Company’s plans, earnings forecasts, and strategies appearing in this presentation are based on the judgement of the Company’s この資料に掲載しております当社の計画および業績の見通し、戦略などは発表日時点において把握できる情報から得られた当社の経営者の management from information obtainab

Tsuruha Holdings — 2Q FY5/21 Earnings Presentation on 6ix